From needles to pills: oral GLP-1 therapy enters the obesity arena
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes
Another semaglutide injection, Wegovy, costs $1,848 per 4, 2.4 mg/0.75 mL autoinjector pens, which is also a one-month supply
Particular attention is given to suppression of the hypothalamicpituitarygonadal axis, impaired spermatogenesis, fertility disturbances, and the potential for long-term or persistent endocrine sequelae
Matt Kaeberlein, the Chief Executive Officer of Optus Span Inc., an affiliate professor at the University of Washington, and a co-founder of the Dog Aging Project
T.KadowakiT.LingvayI.NauckM.et al (2019)